Imran Hamid, MD

Affect Therapeutics is a nation-wide substance use disorder treatment provider for alcohol, marijuana/cannabis, methamphetamine, cocaine, and prescription stimulants. Our wholistic program is delivered through a revolutionary smartphone app that reduces known barriers in access to care and leverages the latest research and technology to achieve incredible results. We use contingency management and other types of rewards systems as engagement techniques as well as harm reduction to keep people working towards their goals. Designed with behavioral engineering and gamification principles, our app stimulates the brains rewards center as people reduce their use of substances and learn to manage the chronic disease of addiction into remission. Accredited by CARF Internation and supported by NIDA and NIH, Affects revolutionary program and technology achieve outcomes more than double of traditional rehab models. Thousands of people who have struggled to break free of addiction have found success with us. We partner with a wide range of organizations who are working to address the nations addiction crisis. We work with referral partners across the treatment sector to provide the appropriate levels of care for each individual. Affect makes care available to communities that do not have access to clinics and it works in a continuum of care so people leaving detox and inpatient can continue to work their recovery programs conveniently and discreetly. Community organizations and partners in the criminal justice system rely on us to support them. Find out more about how Affect works, how you can work with us, and if it can work for you at our website. Our app is free to download and use. The program is covered by Medicaid and we accept many commercial insurance plans. We beat the deadly game of addiction by changing the rules. Win your life back with Affect.

Engineered for rest. Designed for sleep. Get $50 off Ozlo Sleepbuds® - available now at OzloSleep.com 💤

We believe that people having surgery deserve more. They deserve the chance to influence their own outcomes. Having surgery is like running a marathon—both require extensive preparation to get the best results. You wouldnt run a marathon unprepared. Why approach surgery differently? We empower patients to actively prepare—physically, mentally, and emotionally—for a smoother, faster recovery from surgery. Our evidence-backed programme, built on the latest science of behaviour change, helps reduce complications, accelerate recovery, and can sometimes even help avoid surgery altogether. In January 2025, Surgery Hero was acquired by Sword Health, a global leader in digital health. This acquisition not only brings us closer to our mission of helping 100 million people have a successful surgery, but also supports Sword’s mission of freeing 2 billion people from pain.

The company has an early stage pipeline of novel, multi-cistronic gene therapy products targeting diabetic macular edema (DME), age-related macular degeneration (AMD, both wet and dry forms) and ocular hypertension.

We’re developing faster, more effective tools to help our partners solve the biggest healthcare challenges in neurodegeneration and psychiatry. Cumulus Neuroscience has created a next-generation integrated physiological and digital biomarker platform. In clinical trials it provides the critical data and insights needed to accelerate the delivery of more effective CNS drugs to patients. This addresses the significant unmet need for faster, more robust and cost-effective execution and evaluation of clinical trials in neuroscience.

We need to shift to a world where we treat the individual, not just the disease. Our inventions work in combination with medicine to deliver personalized, optimized dosing, to provide bespoke universal healthcare access and improve outcomes for patients with chronic diseases. Closed Loop Medicine is a TechBio company developing combination prescription drug + software products, with the aim of bringing forward the promise of precision care. Our proprietary technology platform facilitates personalized drug dose optimization through integration of medicines and software with patient-led digital experiences and closed loop models of care. To learn more about our mission to deliver #PrecisionCareForAll, please visit: www.closedloopmedicine.com

At DJS we are developing novel therapeutics to treat chronic inflammatory diseases. We do this through the discovery and development of novel therapeutic monoclonal antibodies against GPCRs. Our breakthrough technology enables us to produce first-in-class antibody therapeutics to previously intractable disease targets.

LivaNova PLC is a global medical technology company built on 50+ years of experience and a Vision to change the trajectory of lives for a new day. Our Mission is to create ingenious medical solutions that ignite patient turnarounds. At LivaNova, we understand the importance of bringing both clinical and economic value to our customers. We are a strong, market-leading medical technology and services company, offering a diverse product portfolio and global reach. LivaNova is listed on the Nasdaq stock exchange under the ticker symbol “LIVN.” LivaNova has approximately 3,000 employees worldwide. We are headquartered in London (UK) and maintain a presence in more than 100 countries. As a worldwide leader in cardiopulmonary and neuromodulation, we don’t just treat conditions—we aspire to alter the course of lives. So from patients seeking answers to impossible situations to clinicians striving to do their best work to employees finding a place where they can change the world— Welcome to LivaNova. Welcome to your new life.

Affect Therapeutics is a nation-wide substance use disorder treatment provider for alcohol, marijuana/cannabis, methamphetamine, cocaine, and prescription stimulants. Our wholistic program is delivered through a revolutionary smartphone app that reduces known barriers in access to care and leverages the latest research and technology to achieve incredible results. We use contingency management and other types of rewards systems as engagement techniques as well as harm reduction to keep people working towards their goals. Designed with behavioral engineering and gamification principles, our app stimulates the brains rewards center as people reduce their use of substances and learn to manage the chronic disease of addiction into remission. Accredited by CARF Internation and supported by NIDA and NIH, Affects revolutionary program and technology achieve outcomes more than double of traditional rehab models. Thousands of people who have struggled to break free of addiction have found success with us. We partner with a wide range of organizations who are working to address the nations addiction crisis. We work with referral partners across the treatment sector to provide the appropriate levels of care for each individual. Affect makes care available to communities that do not have access to clinics and it works in a continuum of care so people leaving detox and inpatient can continue to work their recovery programs conveniently and discreetly. Community organizations and partners in the criminal justice system rely on us to support them. Find out more about how Affect works, how you can work with us, and if it can work for you at our website. Our app is free to download and use. The program is covered by Medicaid and we accept many commercial insurance plans. We beat the deadly game of addiction by changing the rules. Win your life back with Affect.

Engineered for rest. Designed for sleep. Get $50 off Ozlo Sleepbuds® - available now at OzloSleep.com 💤

We believe that people having surgery deserve more. They deserve the chance to influence their own outcomes. Having surgery is like running a marathon—both require extensive preparation to get the best results. You wouldnt run a marathon unprepared. Why approach surgery differently? We empower patients to actively prepare—physically, mentally, and emotionally—for a smoother, faster recovery from surgery. Our evidence-backed programme, built on the latest science of behaviour change, helps reduce complications, accelerate recovery, and can sometimes even help avoid surgery altogether. In January 2025, Surgery Hero was acquired by Sword Health, a global leader in digital health. This acquisition not only brings us closer to our mission of helping 100 million people have a successful surgery, but also supports Sword’s mission of freeing 2 billion people from pain.